Depression and Anxiety Trial, Recruiting NCT05645575 Sponsor: University of California, Los Angeles Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05645575
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years old
  • People who have been diagnosed with moderate to severe Major Depressive Disorder (either a single episode or recurring episodes), confirmed by a specific depression rating scale score of 17 or higher
  • People whose depression did not improve after trying at least 2 different antidepressant medications from at least 2 different medication categories
  • People who have also tried at least 2 additional evidence-based treatments used alongside antidepressants (note: benzodiazepines, a type of anti-anxiety medication, do not count toward this requirement)
  • People who have completed a course of talk therapy (psychotherapy) that is recognised as effective for depression, at an appropriate length and frequency
  • People who are willing and able to follow an intensive, accelerated treatment schedule

Who may not be able to join:

  • People who are not able to give informed consent due to mental or legal incapacity
  • People who have an active infection or significantly poor skin condition on the scalp where the treatment device would be placed
  • People who have an increased risk of seizures due to family history, a previous stroke, or current use of medications known to raise seizure risk
  • People who have been diagnosed with psychotic symptoms or conditions — such as schizophrenia or schizoaffective disorder — during their current depressive episode
  • People who have a neurological condition such as epilepsy, a history of stroke or cerebrovascular disease, dementia, increased pressure in the brain, a history of repeated or serious head injury, or a brain tumour
  • People who have a magnetic-sensitive medical device implanted in their body — for example, a cochlear implant, a pacemaker, an implanted heart defibrillator, a vagus nerve stimulator, or certain metal clips, coils, staples, or stents (note: standard dental fillings are considered safe and do not disqualify someone)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 310-825-4781

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
22 February 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Treatment Efficacy as Measured by Change in Inventory of Depressive Symptoms (Self-Report) at Baseline and Final Visit

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov